Therapeutic-interchange program for oral histamine H2-receptor antagonists

American Journal of Health-System Pharmacy

Volumn 55, Issue 13, 1998, Pages 1382-1386

  Chase, Sandra L ^a   Peterson, Andrew M ^b,c   Wordell, Cindy J ^a,d  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c TJUH

^d TJUH

Author keywords

Administration; Cimetidine; Compliance; Costs; Economics; Education; Equivalency, therapeutic; Famotidine; Formulaties; Gastrointestinal drugs; Hospitals; Nizatidine; Nurses; Pharmaceutical services; Pharmacists, hospital; Pharmacy, institutional, hospital; Physicians; Prescribing; Ranitidine

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; RANITIDINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG FORMULARY; DRUG FORMULATION; DRUG MONITORING; DRUG PROGRAM; HOSPITAL PHARMACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHARMACY AND THERAPEUTICS COMMITTEE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 0032126909     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.13.1382     Document Type: Article

References (9)

1. Achusim LE. Therapeutic interchange as a cost-containment measure. Pharmacoeconomics. 1992; 2:347-51.
2. Vander Linde JB, Malburg DE, Fehr SE. Implementation, evaluation and cost savings of a cimetidine capitation and therapeutic interchange program. Paper presented at ASHP Midyear Clinical Meeting. New Orleans, LA; 1991 Dec 12.
3. Rich DS. Experience with a two-tiered therapeutic interchange policy. Am J Hosp Pharm. 1989; 46:1792-8.
4. Martin LA, Watkins JB, Greene SA et al. Procedural compliance and clinical outcome associated with therapeutic interchange of extended-spectrum penicillins. Am J Hosp Pharm. 1990; 47:1551-4.
5. Oh T, Franko TG. Comprehensive therapeutic interchange program in a community hospital. Am J Hosp Pharm. 1991; 48:1471-7.
6. Oh T, Franko TG. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine. Am J Hosp Pharm. 1990; 47:1547-51.
7. Henry VR, Montalvo AA. Therapeutic interchange: one solution in a community hospital. Paper presented at ASHP Annual Meeting. Reno, NV; 1994 Jun 8.
8. Shulman SR, Dicerbo PA, Ulcickas ME et al. A survey of therapeutic substitution programs in ten Boston area hospitals. Drug Inf J. 1992; 26:41-52.
9. American Medical Association. AMA policy on drug formularies and therapeutic interchange in inpatient and ambulatory patient care settings. Am J Hosp Pharm. 1994; 51:1808-10.